Free-Floating Aggregate and Single-Cell-Initiated Biofilms of Staphylococcus aureus

Tripti Thapa Gupta1, Niraj K Gupta1, Peter Burback2

  • 1Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA.

Insights

Staphylococcus aureus forms aggregates in synovial fluid, leading to biofilms that resist antibiotics. This study shows these biofilms develop similarly to planktonic cell biofilms, offering insights into periprosthetic joint infection treatment.

Area of Science:

  • Microbiology
  • Biomedical Engineering
  • Infectious Diseases

Background:

  • Periprosthetic joint infection (PJI) is a significant complication of artificial joint replacement.
  • Staphylococcus aureus is a primary pathogen in PJI, forming biofilms that resist antimicrobial treatments.
  • The development of biofilms from staphylococcal aggregates in synovial fluid under shear stress is not well understood.

Purpose of the Study:

  • To investigate the progression of biofilms formed from Staphylococcus aureus aggregates under shear conditions.
  • To compare the characteristics and antibiotic susceptibility of biofilms derived from aggregates versus planktonic cells.

Main Methods:

  • Biofilms were cultivated in flow cells on titanium discs for 24 hours.
  • Inoculation was performed using either pre-aggregated or single planktonic Staphylococcus aureus cells.
  • Biofilm biomass, surface area, thickness, and antibiotic susceptibility (vancomycin) were analyzed.

Main Results:

  • No significant differences were observed in biofilm biomass, surface area, or thickness between biofilms formed from aggregates and single cells.
  • Biofilms formed from aggregates showed a slightly greater reduction in viable cells (2 log) compared to single-cell biofilms (1 log) after vancomycin treatment.

Conclusions:

  • Staphylococcus aureus aggregates in synovial fluid can initiate biofilm formation with characteristics similar to those from planktonic cells.
  • These biofilms exhibit comparable antibiotic tolerance, highlighting potential challenges in treating PJI caused by aggregated bacteria.